Christine Mikail Cvijic Insider Profile
11 Followers
Christine Mikail Cvijic, Pres. & CFO, Director at Neurogene, holds 84.04K shares in Neurogene (Ticker: NGNE), holds 0.00 shares in NPS Pharma (Ticker: NPSP), holds ― shares in Sio Gene Therapies (Ticker: SIOX).
Christine Mikail Cvijic's Trading History
| NGNENeurogene | Jul 07, 2026 | Pres. & CFO, Director | Uninformative Sell | 173.36K | $2.01M | |
| DNDNQDendreon Corp | Feb 12, 2014 | ― | Uninformative Buy | ― | ― | |
| SIOXSio Gene Therapies | ― | ― | ― | ― | ||
| NPSPNPS Pharma | ― | ― | ― | ― |
You May Also Like
Christine Mikail Cvijic insider profile FAQ
What is the percentage of profitable transactions made by Christine Mikail Cvijic?
The percentage of profitable transactions made by Christine Mikail Cvijic is 0%.
What is the average return per transaction made by Christine Mikail Cvijic?
The average return per transaction made by Christine Mikail Cvijic is -25.10%.
What stocks does Christine Mikail Cvijic hold?
Christine Mikail Cvijic holds: NGNE, NPSP, SIOX, DNDNQ stocks.
What was Christine Mikail Cvijic’s latest transaction?
Christine Mikail Cvijic’s latest transaction was an Uninformative Sell of $173.36K.
What was Christine Mikail Cvijic's most profitable transaction?
Christine Mikail Cvijic’s most profitable transaction was an Informative Sell of NGNE stock on March 17, 2026. The return on the trade was -20.00%.
What is Christine Mikail Cvijic's role in Neurogene?
Christine Mikail Cvijic's role in Neurogene is Pres. & CFO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.